Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Sensei Biotherapeutics, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Sensei Biotherapeutics is a clinical-stage immunotherapy company developing next-generation therapeutics for cancer treatment. The company focuses on innate immunity to develop conditionally-activated immunotherapies designed to overcome tumor resistance mechanisms. Sensei is advancing multiple programs targeting both solid tumors and hematologic malignancies.